Erlotinib

Results: 189



#Item
181Pharmaceuticals | In 2008 the division again delivered strong underlying sales and operating profit growth while

Pharmaceuticals | In 2008 the division again delivered strong underlying sales and operating profit growth while

Add to Reading List

Source URL: www.roche.com

Language: English - Date: 2013-10-06 13:45:42
182Tarceva® (erlotinib) Tablets, NDA[removed], S003: Supplemental NDA Briefing Document – 13 September 2005 ODAC Meeting

Tarceva® (erlotinib) Tablets, NDA[removed], S003: Supplemental NDA Briefing Document – 13 September 2005 ODAC Meeting

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-09-12 09:27:21
183Tarceva® (erlotinib) Tablets, NDA[removed], S003: Supplemental NDA Briefing Document – 13 September 2005 ODAC Meeting

Tarceva® (erlotinib) Tablets, NDA[removed], S003: Supplemental NDA Briefing Document – 13 September 2005 ODAC Meeting

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-09-12 09:27:21
184NDA[removed]S-003 Page 3 Rev[removed]

NDA[removed]S-003 Page 3 Rev[removed]

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-03-31 15:48:48
185

PDF Document

Add to Reading List

Source URL: www.pharmac.govt.nz

Language: English - Date: 2012-08-31 07:00:01
186

PDF Document

Add to Reading List

Source URL: clincancerres.aacrjournals.org

Language: English
187

PDF Document

Add to Reading List

Source URL: arxiv.org

Language: English - Date: 2012-03-18 20:02:50
188Untitled

Untitled

Add to Reading List

Source URL: annonc.oxfordjournals.org

Language: English
189

PDF Document

Add to Reading List

Source URL: media.corporate-ir.net

Language: English - Date: 2007-05-04 10:48:56